ACM
PHXM

ACT Capital Management’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

ACT Capital Management’s Portfolio PHXM Stock Details PHXM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-200
Closed -$12K – 113
2021
Q3 		$12K Hold
200
– – 0.01% 106
2021
Q2 		$10K Buy
+200
New +$12.4K 0.01% 113

Other funds holding PHXM

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

ACT Capital Management's PHXM Position: Q4 2021 in Review

ACT Capital Management sold out of PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) in Q4 2021, closing a stake of 200 shares — an estimated $12K sold.

ACT Capital Management first reported a position in PHXM in Q2 2021 and held it in 2 quarters. The position peaked at $12K in Q3 2021. 9 funds tracked by Wall St. Rank hold PHXM as of Q4 2021.

  • ACT Capital Management reported no remaining PHAXIAM Therapeutics S.A.. American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • ACT Capital Management sold 200 PHAXIAM Therapeutics S.A.. American Depositary Shares shares in Q4 2021, an estimated $12K.
  • ACT Capital Management first reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares in Q2 2021 and held it in 2 quarters.
  • ACT Capital Management's PHAXIAM Therapeutics S.A.. American Depositary Shares position peaked at $12K in Q3 2021.
  • 9 funds tracked by Wall St. Rank held PHAXIAM Therapeutics S.A.. American Depositary Shares as of Q4 2021.

Based on ACT Capital Management's 13F filing for Q4 2021, filed 3 Feb 2022.